BioAffinity Technologies Inc. (BIAF)
NASDAQ · Healthcare
BioAffinity Technologies Inc. Operating Income 2022–2025
BioAffinity Technologies Inc. annual/quarterly operating income history and growth rate from 2022 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- BioAffinity Technologies Inc. operating income for the quarter ending March 31, 2026 was -3.6 M, a 37.68% increase year-over-year.
- BioAffinity Technologies Inc. operating income for the twelve months ending March 31, 2026 was -11.1 M, a 33.14% increase year-over-year.
- BioAffinity Technologies Inc. annual operating income for 2025 was -10.6 M, a 18.08% increase from 2024.
- BioAffinity Technologies Inc. annual operating income for 2024 was -9.0 M, a 12.29% increase from 2023.
- BioAffinity Technologies Inc. annual operating income for 2023 was -8.0 M, a 98.78% increase from 2022.
- BioAffinity Technologies Inc. annual operating income for 2022 was -4.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BioAffinity Technologies Inc. Operating Income — FAQ
BioAffinity Technologies Inc. (BIAF) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is BioAffinity Technologies Inc.'s operating income?
BioAffinity Technologies Inc. (BIAF) reported operating income of -$11M for fiscal 2025.
Where can I see BIAF's operating income history?
The chart and table above show BioAffinity Technologies Inc.'s operating income by year and by quarter, including the growth rate.